Intrinsic Edge Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24,900	Closed	-$1.49M	–	134
2023 Q3	$1.49M	Buy	+24,900	New	+$1.49M	0.17%	96
2017 Q2	–	Sell	-19,236	Closed	-$1.27M	–	132
2017 Q1	$1.27M	Buy	+19,236	New	+$1.27M	0.39%	81